Delivery Order SPE2DR25D3111-SPE2DR26FF3JE
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,453.70. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, PA. The award represents a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a $2,096.15 delivery order (Contract #4570222313) by the Defense Logistics Agency for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed price delivery order, awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a non-competitive, competitively awarded transaction under the company's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,252.25 by the Defense Logistics Agency on July 23, 2025. The contract calls for delivery of Trulicity 3 mg/0.5 ml pens (0.5ml units), a diabetes medication commonly used within military and federal healthcare systems. This is a non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,160.00 by the Defense Logistics Agency (DLA) on December 16, 2025. The contract, which is set for completion by December 17, 2025, calls for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities. This is a firm fixed-price delivery order issued as a child contract under a larger vehicle, reflecting DLA's pharmaceutical procurement...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,302.84 for Trulicity 1.5 mg/0.5 ml pens by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price contract is not set-aside and represents a single delivery of the diabetes medication to support military healthcare operations. The award is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,878.61 by the Defense Logistics Agency (DLA) on September 18, 2025, with a completion date of September 19, 2025. The contract covers the supply of Trulicity 1.5 mg/0.5 mL pen injectable medication, a diabetes treatment. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3JEDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,017.52 by the Defense Logistics Agency on November 24, 2025, with completion targeted for November 25, 2025. The contract (4570091594) involves the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL), a diabetes medication commonly used within military and federal healthcare systems. This delivery order was competitively awarded without set-aside designation under a firm fixed-price structure, reflecting standard federal procurement practices for pharmaceutical commodities. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and federal beneficiaries worldwide. The company's demonstrated capability to fulfill competitive awards across multiple therapeutic domains, combined with its significant IDC capacity, positions it as a critical vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/23/25 |